Private company

Neurobiological Technologies

Biotechnology company (1987–2009)

Neurobiological Technologies, Inc. ("NTI") was a biotechnology company that was founded in 1987 by Enoch Callaway and John B. Stuppin to in-license and develop drugs primarily to treat neurological conditions; the company was dissolved in 2009 after the failure of its drug candidate ancrod in a Phase III trial for ischemic stroke.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

Neurobiological Technologies, Inc. ("NTI") was a biotechnology company that was founded in 1987 by Enoch Callaway and John B. Stuppin to in-license and develop drugs primarily to treat neurological conditions; the company was dissolved in 2009 after the failure of its drug candidate ancrod in a Phase III trial for ischemic stroke.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2